Stay updated on AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page.

Latest updates to the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page
- Check2 days agoChange DetectedThe record history now shows Revision: v3.3.3; the items HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision history shows the addition of Revision: v3.3.2 and the removal of Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check31 days agoChange DetectedRecord History now shows Revision: v3.3.1 replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedThe site-wide funding lapse notice was removed from the page. The page now shows only the standard study information and navigation.SummaryDifference0.8%

- Check53 days agoChange DetectedA new version was posted showing a Recruitment Status update for NCT05255094. The history now reflects the latest recruitment status for this study.SummaryDifference0.1%

- Check81 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference13%

Stay in the know with updates to AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK102 Efficacy and Safety in Hyperlipidemia Clinical Trial page.